Cannabis
It's the Bigger Players Who'll Benefit as Cannabidiol Sales Are Cut by Covid
New CBD companies are finding it difficult to enter retail channels.
Cannabis Grower Aphria Will Likely Build a Bigger Base in the Months Ahead
APHA's strategy is to perfect operations in Canada so that they'll be ready when cannabis is legalized in the U.S.
This Is Likely a Good Time to Dial Things Back and Observe the Action
Anyone playing the guessing game into earnings is rolling the dice.
Fire Up Your Portfolio With This Dividend King
Altria has future growth potential, over 50 years of dividend increases and a high yield exceeding 8%.
Canopy Growth Proves: Where There's Smoke, There's Fire
CGC has started to make its move to the upside, so let's see what the charts say and how to play this cannabis name.
Totally Out There: Our Top 5 Psychedelic Stocks
Investors are anxious to grab the next penny stock that may be poised to jump on the mind-blowing bubble. Here they are.
Don't Forget the Motor City: Corporate Cannabis on Sidelines for Michigan
A messy situation hangs over a state that could rival Colorado or Illinois for sales.
There Are Quite a Few Moving Parts to This Market
It's a mistake to declare the action as either bullish or bearish.
Trulieve Bucks the Cannabis Trend
How is Trulieve accomplishing what so many other cannabis companies have attempted and failed?
Take Advantage of This Action While You Can
My focus remains on individual stock picking. The market timers are being crushed again.
Village Farms Has More Going for It Than Most of the Other Cannabis Names
The daily picture has my attention. The big watch here is the 50-day simple moving average.
Convenience Stores Eagerly Await Cannabis Products
There are 153,000 convenience stores in the U.S. and these outlets sell the bulk of the country's cigarettes.
Constellation Brands Is Ready to Break a Long-Term Downtrend
Here's our latest trading strategy on STZ.
Cannabis Is Not Happening in Vegas
Experts predict it could take 12-18 months for the market to recover.
Cannabis Companies Eyeing How Plant Could Help Autism Symptoms
After finding success in treatment for epilepsy and other conditions, some in the industry are focusing on autism spectrum disorder.
An Upside Move for Canopy Growth Could Be Coming Soon
Here's how investors can trade the cannabis stock.
6 Cannabis Stock Plays Investors Should Know About
This six-pack from investment specialists includes a REIT and a software provider specializing in the industry.
Cannabis Company Eyes Medicinal Magic of Mushrooms
Mydecine Innovations Group -- formerly known as NewLeaf -- signed an agreement with the University of Alberta's Faculty of Pharmacy and Pharmaceutical Sciences.
Innovative Industrial Properties: A 4%+ Dividend Yield and Growth From Cannabis
Not many marijuana stocks pay dividends, so income investors have a unique opportunity with this REIT.
Cannabis SPACs Are the Only Game in Town
With over $2.5 billion raised by SPACs in the cannabis industry, there is more buying power in the market that is fueling new M&A activity.
TerrAscend Gains Ground in 2020
The cannabis name is budding into a serious contender in the industry -- and is catching the eyes of impressed analysts.
Canopy Growth Could Continue to Base Awhile but the Long-Term Looks Promising
Put CGC on your potential shopping list and let's keep an eye on it.
Cannabis Shoppers Prefer the In-Store Experience
The quick return to cannabis dispensaries shows that the demise of brick and mortar is a myth.
The Market Is Setting Up for the Next Big Move
Despite the lackluster action there are some pockets of good stock picking again.
Coming This Summer: A Lot Less Travel and a Lot More Market Action
That doesn't mean we'll move straight up over the summer, but we'll get plenty of virus, China, stimulus, cannabis, and unemployment chatter.
Cannabis Trades Into the Weekend
One notable area of trading on Thursday was the pot stocks, and I expect to see that continue as speculative traders look for some 'holiday' trading.
Cannabis Cos. Ready for Sales to Heat Back Up in Massachusetts
State's dispensaries get OK to reopen recreational curbside service on May 25.
GW Pharmaceuticals Looks Like It Is Ending Its Downtrend
Time to go long?
Has Investing in Chinese Stocks Gone to Pot?
Political games of smoke and mirrors are making Asian trades look risky, but there may be another opportunity sprouting up.
Covid-19 Is Not Hurting the Cannabis Industry
Still, Covid has forced attention on company balance sheets and a hard look at cash burn rates and investment choices.